Literature DB >> 16735717

Progesterone receptor in estrogen receptor-positive breast cancer: the association between HER-2 and lymph node involvement is age related.

Patrick Neven, Nathalie Pochet, Maria Drijkoningen, Frederic Amant, Frank De Smet, Robert Paridaens, Marie-Rose Christiaens, Ignace Vergote.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16735717     DOI： 10.1200/JCO.2005.05.1334

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Resistance to HER2-targeted therapies: a potential role for FOXM1.

Authors:  Bridgette F Peake; Rita Nahta
Journal:  Breast Cancer Manag       Date:  2014

Review 2.  A review of an unfavorable subset of breast cancer: estrogen receptor positive progesterone receptor negative.

Authors:  Jigisha P Thakkar; Divyesh G Mehta
Journal:  Oncologist       Date:  2011-02-21

3.  Male breast cancer according to tumor subtype and race: a population-based study.

Authors:  Mariana Chavez-Macgregor; Christina A Clarke; Daphne Lichtensztajn; Gabriel N Hortobagyi; Sharon H Giordano
Journal:  Cancer       Date:  2013-01-22       Impact factor: 6.860

4.  Molecular Insights into the Classification of Luminal Breast Cancers: The Genomic Heterogeneity of Progesterone-Negative Tumors.

Authors:  Gianluca Lopez; Jole Costanza; Matteo Colleoni; Laura Fontana; Stefano Ferrero; Monica Miozzo; Nicola Fusco
Journal:  Int J Mol Sci       Date:  2019-01-25       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.